Detalhe da pesquisa
1.
Targeting Oncogenic Mutant p53 and BCL-2 for Small Cell Lung Cancer Treatment.
Int J Mol Sci
; 24(17)2023 Aug 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37685889
2.
BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer.
Cancers (Basel)
; 15(16)2023 Aug 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37627092
3.
NOXA expression is downregulated in human breast cancer undergoing incomplete pathological response and senescence after neoadjuvant chemotherapy.
Sci Rep
; 13(1): 15903, 2023 09 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37741850